SCHEMBL6432318

SCHEMBL6432318

CC(=O)Oc1ccc(NC(=O)CCc2cnn(-c3ccccc3)c2-c2ccccc2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.49
TSHR P16473 1/20 0.47
HTT P42858 1/20 0.47
HSD17B10 Q99714 1/20 0.47
MAPT P10636 5/20 0.44
ALDH1A1 P00352 3/20 0.44
CYP2C9 P11712 2/20 0.43
CYP2C8 P10632 1/20 0.43
HCAR2 Q8TDS4 1/20 0.43
NPC1 O15118 1/20 0.43
PKM P14618 1/20 0.43
RAB9A P51151 1/20 0.43
HDAC3 O15379 1/20 0.42
HDAC1 Q13547 1/20 0.42
HDAC2 Q92769 1/20 0.42
HDAC10 Q969S8 1/20 0.42
HDAC8 Q9BY41 1/20 0.42
HDAC6 Q9UBN7 1/20 0.42
HSP90AA1 P07900 1/20 0.41
TP53 P04637 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4826152 0.86 MAPT (0.51) TSHRHTTMAPTALDH1A1NPC1
SCHEMBL4836350 0.85 CYP2C9 (0.46) GAATSHRMAPTALDH1A1CYP2C9
SCHEMBL4826040 0.83 NPC1 (0.44) HTTMAPTCYP2C9CYP2C8HCAR2
SCHEMBL4831316 0.82 ALDH1A1 (0.49) MAPTALDH1A1CYP2C9CYP2C8HCAR2
SCHEMBL4828997 0.81 ENPP2 (0.44) GAATSHRHTTMAPTALDH1A1
SCHEMBL4834870 0.80 ALDH1A1 (0.43) GAAHTTMAPTALDH1A1CYP2C9
SCHEMBL6533070 0.80 HCAR2 (0.51) MAPTALDH1A1CYP2C9CYP2C8HCAR2
SCHEMBL4834860 0.79 MAPT (0.44) GAAMAPTALDH1A1CYP2C9CYP2C8
SCHEMBL4833579 0.76 ALDH1A1 (0.51) HTTMAPTALDH1A1CYP2C9NPC1
SCHEMBL4976919 0.71 ALDH1A1 (0.54) TSHRHTTHSD17B10MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1556032-A1 AGENT FOR PREVENTING OR TREATING NEUROPATHY Takeda Pharmaceutical Company Limited (JP) 2005-07-27 EP disclosed
WO-2004039365-A1 AGENT FOR PREVENTING OR TREATING NEUROPATHY TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-05-13 WO disclosed